Figure 1
From: [18F]FDG-6-P as a novel in vivo tool for imaging staphylococcal infections

Determination of the purity of [ 18 F]FDG-6-P. By (a) iTLC at 0 h and (b) RP-HPLC after incubation of the radiopharmaceutical in water for 3 h. The retention profiles of [18F]FDG-6-P were easily resolved from that of [18F]FDG, the most likely breakdown product of [18F]FDG-6-P. No changes in the [18F]FDG-6-P peak or retention time were observed.